Preimplantation genetic testing to reduce preterm births in assisted reproductive technology

The 10% rate of preterm birth rate worldwide has not been proved amenable to reduction. Avoiding multiple embryo transfer in assisted reproductive technologies (ART) using in vitro fertilization is one unassailable method. Preimplantation genetic testing (PGT) to select only a single euploid embryo for transfer is one unequivocal way, maintaining 50%–60% pregnancy rates while avoiding twins. Contemporary methodology entails trophectoderm biopsy of a 5–6‐day blastocyst, and cryopreservation of biopsied embryos while awaiting analysis by next generation sequencing. Embryo biopsy is safe, analytic validity for chromosomal analysis high, and global access to PGT high. Multiple gestations secondary to transferring multiple embryos in Assisted Reproduction Technology result in preterm birth. This can be avoided by transfer of a single euploid embryo.